ShaMaran Petroleum Corp. (STO:SNM)

Inozyme Pharma Revenue

ShaMaran Petroleum had revenue of $35.89M USD in the quarter ending March 31, 2025, with 58.87% growth. This brings the company's revenue in the last twelve months to $122.69M, up 97.59% year-over-year. In the year 2024, ShaMaran Petroleum had annual revenue of $109.39M with 31.98% growth.

• Revenue (ttm): $122.69M
• Revenue Growth: +97.59%
• P/S Ratio: 3.35
• Revenue / Employee: $13.63M
• Employees: 9
• Market Cap: 4.13B

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	109.39M	26.51M	31.98%
Dec 31, 2023	82.89M	-93.78M	-53.08%
Dec 31, 2022	176.67M	74.34M	72.65%
Dec 31, 2021	102.32M	45.65M	80.55%
Dec 31, 2020	56.67M	-13.62M	-19.37%